Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$50.45 - $72.82 $31,228 - $45,075
619 Added 2.58%
24,583 $1.29 Million
Q1 2023

May 12, 2023

BUY
$51.25 - $79.34 $320,261 - $495,795
6,249 Added 35.28%
23,964 $1.53 Million
Q4 2022

Feb 09, 2023

SELL
$46.82 - $76.2 $20,975 - $34,137
-448 Reduced 2.47%
17,715 $860,000
Q3 2022

Nov 14, 2022

BUY
$70.55 - $111.58 $1.28 Million - $2.03 Million
18,163 New
18,163 $1.28 Million
Q2 2022

Aug 04, 2022

SELL
$50.24 - $80.48 $508,278 - $814,216
-10,117 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$57.98 - $93.5 $159,850 - $257,779
2,757 Added 37.46%
10,117 $808,000
Q4 2021

Feb 10, 2022

SELL
$88.02 - $127.79 $268,725 - $390,142
-3,053 Reduced 29.32%
7,360 $672,000
Q3 2021

Nov 12, 2021

BUY
$122.75 - $162.68 $1.28 Million - $1.69 Million
10,413 New
10,413 $1.34 Million
Q2 2021

Aug 10, 2021

SELL
$105.76 - $154.96 $1.33 Million - $1.94 Million
-12,545 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$78.5 - $126.48 $801,485 - $1.29 Million
-10,210 Reduced 44.87%
12,545 $1.32 Million
Q4 2020

Feb 10, 2021

SELL
$55.93 - $82.78 $1.03 Million - $1.53 Million
-18,448 Reduced 44.77%
22,755 $1.8 Million
Q3 2020

Nov 12, 2020

BUY
$45.65 - $61.81 $182,326 - $246,869
3,994 Added 10.73%
41,203 $2.33 Million
Q2 2020

Aug 13, 2020

SELL
$29.15 - $61.54 $2.35 Million - $4.96 Million
-80,624 Reduced 68.42%
37,209 $2.29 Million
Q1 2020

May 14, 2020

BUY
$25.01 - $42.4 $2.95 Million - $5 Million
117,833 New
117,833 $3.8 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.11B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.